Now live: Pro — the full 13F research suite for serious investorsSee pricing →
SB INVESTMENT ADVISERS (UK) LTD

Q4 2023 · 13F-HR

SB INVESTMENT ADVISERS (UK) LTDholdings as filed

Filed 2024-02-14 · accession 0001493152-24-006311

$11.24B
Reported value
13
Positions
2023-12-31
Period end
View analyzed profile →PRO

Holdings as filed

CUSIPTickerIssuerValue% port.SharesClassVoting
22266T109CPNGCOUPANG INC$6.41B57.1%396,156,413CommonSOLE
G4124C109GRABGRAB HOLDINGS LIMITED$1.85B16.5%549,175,218CommonSOLE
25809K105DASHDOORDASH INC$936.1M8.33%9,465,912CommonSOLE
G76279101ROIVROIVANT SCIENCES LTD$820.1M7.30%73,031,667CommonSOLE
20464U100COMPCOMPASS INC$385.3M3.43%102,470,273CommonSOLE
75943R102RLAYRELAY THERAPEUTICS INC$307.2M2.73%27,904,963CommonSOLE
051774107AURAURORA INNOVATION INC$172.3M1.53%39,417,358CommonSOLE
92764N102VIRVIR BIOTECHNOLOGY INC$167.8M1.49%16,684,041CommonSOLE
35969L108YMMFULL TRUCK ALLIANCE CO LTD$88.3M0.79%12,594,110CommonSOLE
29280W109NRGVENERGY VAULT HOLDINGS INC$43.2M0.38%18,535,631CommonSOLE
37611X100DNA4EURGINKGO BIOWORKS HOLDINGS INC$41.3M0.37%24,429,191CommonSOLE
37427G101GETRGETAROUND INC$5.1M0.05%21,516,384CommonSOLE
92671V304VIEW INC$4.0M0.04%1,103,235CommonSOLE

Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.